Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Scimago
- Ulrich's Periodicals Directory
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- Scientific Indexing Services (SIS)
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Astrid Vargstrom
Department of Nanomedicine, City University of Hong Kong, Hong Kong
Publications
-
Opinion Article
Nanobiopharmaceutics: Enhancing Bioavailability and Targeted Therapy
Author(s): Astrid Vargstrom*
Nanobiopharmaceutics is an emerging field that integrates nanotechnology with pharmaceutical sciences to develop advanced drug delivery systems that improve bioavailability and therapeutic efficacy. By utilizing nanoparticles, liposomes, and polymeric carriers, this field enables precise targeting of diseased cells, reduces side effects, and enhances drug stability. Recent innovations in nanobiopharmaceutics have led to significant advancements in controlled drug release, personalized medicine, and treatment strategies for chronic diseases such as cancer and neurodegenerative disorders. However, challenges such as toxicity, regulatory concerns, and scalability must be addressed to ensure the successful translation of nanobiopharmaceuticals from research to clinical applications. This article explores key innovations, benefits, challenges, and future directions in nanobiopharmaceutics... View more»